Introducing BioEye: Visionary Mobile Health Technology
BioEye is an innovative smartphone app created to assess brain health by analysing ocular biomarkers. The ocular motor system is responsible for the appropriate transmission of visual information. It controls the volume and angle of light that enters the eye as well as voluntary and involuntary eye movements.
BioEye’s proprietary eye-tracking platform can accurately and consistently quantify brain health measurements in real-time. This technology offers a non-invasive and easily accessible method for measuring brain health. By analysing ocular biomarkers, which are directly linked to specific areas of the brain, BioEye provides valuable insights into brain function and has the potential to revolutionise the field of neuroscience.
Accessible Brain Health Assessment with BioEye’s Smartphone App
BioEye’s smartphone app offers a highly accessible and affordable solution for assessing brain health. The app’s user-friendly interface enables individuals to utilise the tool regardless of location. Armed with this information, users can make informed decisions about how to manage their brain health proactively.
One of the most valuable features of the app is its ability to collect and maintain an ongoing record of an individual’s brain health data over time. This record allows users to track their progress, identify deficiencies early and assess the effectiveness of any interventions or changes they may make to improve their brain health.
How It Works: Using Eye-Tracking to Measure Brain Health
BioEye’s app operates through the presentation of stimuli on the smartphone screen, followed by recording and analysing the user’s eye responses. After completing a 60-second evaluation test, the app generates a simple result detailing whether the user’s brain health falls within normal ranges or if it has deviated below previous performance.
This tool’s versatility and widespread accessibility enables it to be employed by individuals, regardless of location. Additionally, our app is structured to facilitate periodic retesting, including in the event of significant concerns or with changes in the user’s cognitive function.
The Science Behind BioEye: Proven Methods and Sophisticated Algorithms
The science behind the BioEye app is based on reliable methods of measuring eye movements to better assess brain health. Signals associated with the eyes are distributed across a network that includes most of the brain, and damage to this network manifests as measurable and stereotypical abnormalities in eye movement.
The eye-tracking platform can detect these abnormalities, and its sophisticated algorithms can quantify brain health measurements with accuracy and consistency.
Eye movements have been measured by healthcare professionals for decades as a valuable tool to evaluate brain health. Extensive evidence substantiates the effectiveness of the eye-tracking tests incorporated in the BioEye technology, demonstrating their ability to detect neurological diseases with great sensitivity. This field has seen remarkable progress, with over 35,000 published research papers. At BioEye, we have taken a significant leap forward by digitalising conventional and proven testing procedures, enabling us to deliver an accurate and objective outcome directly to a smartphone.
Validated Through Clinical Trials: BioEye’s High Sensitivity to Concussion
BioEye’s eye-tracking platform has been validated through the performance of over 7,000 tests, compared with scientific grade eye trackers and within prospective clinical trials, to be published later in 2023. In particular, its sensitivity and specificity to concussion has been demonstrated to be extremely high, making it an effective tool for detecting head trauma in individuals.
BioEye in the Battle Against Neurodegenerative Diseases
BioEye represents a promising tool in the battle against neurodegenerative diseases, such as Alzheimer's, Parkinson’s, Multiple sclerosis (MS) and other serious or life-threatening diseases. The eye-tracking techniques and AI algorithms used by BioEye can detect subtle changes that serve as biomarkers for these conditions.
Taking Control of Your Brain Health with BioEye’s Affordable and Scalable Platform
Overall, BioEye is a groundbreaking technology that can change how we assess and manage brain health. Its affordability, accessibility, and accuracy make it a valuable tool for anyone who wants to take control of their brain health and make informed decisions about managing it. BioEye’s smartphone app provides a quick, easy, and effective way to assess and monitor brain health and can potentially improve people’s lives worldwide.
The BioEye Backstory
The BioEye Leadership Team comprises seasoned professionals in technology, business and medical research. Our combined expertise has resulted in the groundbreaking BioEye app, leveraging advanced eye-tracking technology for measuring brain health.
Driven by our purpose, we aim to improve lives by making cutting-edge brain health technology accessible and affordable for all. We are committed to advancing ocular motor technologies, ensuring BioEye's trailblazing status in the industry and delivering precise, reliable assessments of brain health.
About Digital Health Innovation Summit 2023
Join World BI for its 23rd rebranded edition of the Digital Health Innovation Summit – a unique opportunity to connect with thought leaders from the pharma, healthcare, and medtech industries, while learning about the newest trends in digital health technologies and clinical trial innovation.
This new conference provides you with industry recommendations, case studies, and the actionable insights you need to transform your own projects and strategically bring it to the next level through scientific discovery, collaborative research, medtech entrepreneurship, and pharma-tech partnerships.
Join us to learn from the best in the drug development industry, including clinicians, scientists, entrepreneurs, biomedical engineers, patient advocates, and top technology providers across the globe. And if that’s not enough, the conference will be held at the Hyatt Regency San Francisco Embarcadero Waterfront Hotel.